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31P magnetic resonance spectroscopy can be used to study phosphorus metabolism
in the liver non-invasively. Spectral resolution and signal-to-noise ratio (SNR) are
critical issues in in vivo 31P MRS, since relevant peaks overlap partly and the
NMR sensitivity of 31P is only 6 % of protons sensitivity. Spectral resolution
and sensitivity in 31P MRS can be improved by applying a proton-decoupling
and nuclear Overhauser schemes to the measurement sequence. However, nuclear
overhauser enhancement is individual for each metabolite and may have inter-
individual variation as well.
In this thesis, the effects of line broadening and noise on hepatic 31P MR spectra
were studied through simulations. In addition, hepatic in vivo proton-decoupled
31P MRS measurement were performed on healthy subjects to determine SNR, and
inter- and intra-individual variations for each metabolite. Information obtained
from simulated spectra were utilized in the analysis of in vivo spectra.
In this thesis, lineshape fitting combined with prior knowledge was insensitive
to noise. Lorentzian lineshape fit tends to overestimate broad resonances if not
normalized by total phosphorus signal, while Gaussian lineshapes are insensitive
to inhomogeneaous broadening, but underestimate signal intensities. Lorentzian
compared to Gaussian approach resulted lower variation in in vivo spectra: inter-
and intra-individual coefficient of variations for Gaussian fitting procedure ranged
from 24-67% and 7-60%, and Lorentzian 10-43% and 2-59%, respectively. These
variations can be utilized in power calculations for clinical studies.
Keywords: Nuclear magnetic resonance, 31-Phosphorus magnetic resonance
spectroscopy, Liver
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Symbols
B magnetic field
k Boltzmann’s contant ≈ 1.3805× 10−23[J/K]
h Planks’s contant ≈ 6.62607× 10−34[m2kg/s]
γ gyromagnetic ratio
ν0 Larmor frequency
r internuclear distance
η nuclear Overhauser enhancement
ρL reflection coefficient
τC correlation time
M0 net magnetization
Mz longitudinal magnetization
Mxy transverse magnetization
T1 longitudinal i.e. spin-lattice relaxation
T2 transverse i.e. spin-spin relaxation
31P phosphorus isotope with mass number of 31
1H hydrogen isotope with mass number of 1 (proton)
19F fluorine isotope with mass number of 19
13C carbon isotope with mass number of 13 (proton)
Opetators
d
dt
a derivative in respect to time (t)
∂
∂t
the partial derivative in respect to t.∫∞
−∞
improper integral with infinite endpoints
viii
Abbreviations
AFP adiabatic full passage pulse
AHP adiabatic half passage pulse
AMARES advanced method for accurate, robust, and efficient spectral fitting
AMP adenosine monophosphate
ATP adenosine triphosphate
CRB Crame´r-Rao bound
CRLB Crame´r-Rao lower bound
CSA chemical shift anisotropy
CV coefficient of variation
DW-MRI diffusion weighted magnetic resonance imaging
emf electromotive force
FID free induction decay
GPC glycerophosphorylcholine
GPE glycerophosphorylethanolamine
HS hyperbolic secant
HS-EX hyperbolic secant excitation
ISIS image selected in vivo spectroscopy
LWHM line width at half maximum
MRE magnetic resonance elastography
MRI magnetic resonance imaging
MRS magnetic resonance spectroscopy
NADPH nicotinamide adenine dinucleotide phosphate
NMR nuclear magnetic resonance
NOE nuclear overhauser effect
NS number of scans
NTP nucleoside triphophate
PB pencil beam
PDE phosphodiesters
PC phosphocholine
PCr phosphocreatine
PE phosphoethanolamine
PEP phosphoenolpyruvate
Pi inorganic phosphates
PME phosphomonoesters
PtdC phosphatidylcholine
RF radiofrequency
RG receiver gain
PRESS point resolved spectroscopy
RMS root mean square
SD standard deviation
SNR signal-to-noise-ratio
SR spin rotation
STEAM stimulated echo acquisition mode
UDPG uridine diphosphoglucose
T2DM type 2 diabetes mellitus
TE echo time
TR repetition time
WALTZ-4 wideband alternating-phase low-power technique for zero-residual splitting
1 Introduction
1.1 A brief history to 31P magnetic resonance spectroscopy
Nuclear magnetic resonance (NMR) is based on magnetic properties of nuclei. Felix
Bloch and Edward Mills Purcell (along with their research groups) discovered that
absorption and emission of electromagnetic radiation can be observed when nuclei
are placed in a strong external magnetic field [1, 2]. Bloch and Purcell were jointly
awarded the Nobel Prize in physics in 1952 for their pioneering achievements.
Another giant leap towards an application of NMR spectroscopy was taken in
1950, when Proctor and Yu discovered that nuclei within the same molecule ab-
sorb energy at different resonance frequencies - a phenomena known as chemical
shift [3]. In 1966, Ernst and Andersson introduced pulsed NMR in combination
with Fourier transformation, which is the basis of all modern NMR experiments [4].
Ernst continued his pioneering work on methodology of NMR spectroscopy and he
later had major contribution in the development of multi-dimension spectroscopy.
In 1991, Ernst received the Nobel Prize in chemistry ”for his contributions to the de-
velopment of the methodology of high resolution nuclear magnetic resonance (NMR)
spectroscopy”.
The first NMR experiments on biological tissue were performed in Scandinavia
by a Swedish physician Erik Odeblad in mid-1950s. In Stanford in 1953, Felix Bloch
had been refused Odeblad to use his NMR spectrometer and made clear that ”NMR
was a tool for physicists, not for research into physiology, medicine, or biology”. In
Stockholm, Gunnar Lindstro¨m had built his own NMR instrument around 1950.
After his fellow year in California, Odeblad came back to Sweden, was allowed to
modify Lindstro¨m’s machine and started his experiments on tissue samples [5]. Their
first NMR results revealed that different tissues had distinct relaxation times and
the observation was published in Acta Radiologica in 1955 [6].
In 1971, Dr. Raymond Damadian reported that NMR properties of malignand
tumorous tissue differs from normal tissue, suggesting that proton NMR may have
diagnostic value [7]. Although, the observation was false per se, it was extremely
important to the development of MRI, since it got attention from financiers. Less
than two years later he filed his idea for using magnetic resonance imaging as a
tool for medical diagnosis with the U.S. Patent Office, entitled ”Apparatus and
Method for Detecting Cancer in Tissue.” A U.S. patent was granted in February
1974 [8] and it was the world’s first patent issued in the field of MRI. By 1977,
Dr. Damadian completed construction of the first whole-body MRI scanner and
the FONAR Corporation company he formed in 1978 produced the first commercial
scanner in 1980.
Nearly 20 years after Odeblad described NMR-properties of biologic tissue, Lauter-
bur and Mansfield described a major application of modern in vivo NMR imaging
or later known as magnetic resonance imaging (MRI)[9, 10, 11]. They were able
to reconstruct the spatial distribution of the spins in form of an image by applying
position dependent magnetic fields in addition to static magnetic field. In 2003,
Lauterbur and Mansfield were jointly awarded the Nobel Prize in physiology and
2medicine ”for their discoveries concerning magnetic resonance imaging”.
The first experiments of the 31P NMR spectroscopy on intact living tissues were
reported on early 1970s: Moon and Richard showed how intracellular pH of intact
red blood cells can be determined from chemical shift differences [12] and in 1974,
Hault et al. reported their NMR experiments on intact, excised rat hind leg [13].
Until the beginning of 1980s, all 31P NMR spectroscopy studies, with probably
only one exception [14], were carried out on excised, perfused organs and tissues
obtained through a process requiring some form of invasive surgery. In 1980, first
in vivo 31P MRS studies on small animals were published. Spatial localization was
performed using surface coils and utilizing static-field gradients [15, 16]. Animal
studies were followed by first in vivo studies on human liver in mid-1980s [17, 18]
and by the end of the decade, broadband decoupling had already been utilized in
hepatic 31P MRS at 1.5 T [19].
Higher field strengths are appealing for MRS experiments of the nuclei with
lower concentrations or lower MR sensitivity compared to proton (1H), including 31P.
Since 3.0 Tesla become mainstream field strength in clinical use from the mid 2000s,
in practise, almost all clinical imagers are either 1.5 Tesla or 3.0 Tesla machines.
Recently, first commercial 7.0 Tesla imagers have become available for clinical use,
but installations are still rare.
Nowadays, in vivo NMR spectroscopy is widely used to study brain, liver and
muscle metabolism, and it has several clinical applications. However, it is relatively
time consuming and requires expertised personnel. Therefore, the role of in vivo
MRS in clinical diagnostics remains marginal.
1.2 Methods to study liver metabolism
Liver is vital and unique organ with dual blood supply. Liver is connected to hepatic
artery and the portal vein. Former carries oxygen-rich blood from the aorta and the
latter nutrient-rich blood from the gastrointestinal tract. Liver has numerous func-
tions such as maintenance of blood glucose levels and clearing harmful substances
from the blood, and is thus interesting target for research. Moreover, several liver
disease have malign and progressive nature, and need to be diagnosed at early stage
in order to obtain successful treatment.
Currently liver biopsy remains as a golden standard for diagnosing inflammation
and fibrosis in the liver, but it’s also sensitive for bleeding due to vascular structure
and strong blood supply of the liver. Liver biopsy has been reported to cause pain
for some patients and it requires postoperative surveillance in the hospital. Even
a small, but existing mortality has been reported to be involved with liver biopsy
[20]. For ethical reasons, it’s not allowed to take liver tissue samples from healthy
subjects and therefore liver biopsy is unsuitable for a great number of academic
studies. Liver biopsy has another major limitation: biopsy samples represent only
approximately 1/50000 of the total liver volume. Therefore, sampling errors are
frequent [21, 22].
Due to these complication risks and sampling errors, there is need for non-
invasive approaches in basic research as well as in clinical diagnostics. The human
3liver is attractive target for magnetic resonance spectroscopy studies: it’s metaboli-
cally active and relatively homogeneous organ. Relatively large volume and superfi-
cial location allow generous acquisition volumes and proximal placement of a surface
coil, respectively.
1.3 Hepatic 31P MRS
Proton (1H) MR spectroscopy is a well-established method used to quantify liver
fat [23]. (13C) MR spectroscopy has been used to quantitate glycogen storage in
the liver and (19F) MRS to monitor the metabolism of fluorinated drugs in the
human liver [24, 25]. Moreover, 31P is a very attractive isotope for liver NMR spec-
troscopy, since 31P has a natural abundance of almost 100 % (Table 1) and it’s con-
centrated in a relatively small variety of moieties. NMR visible phosphorus signals
in the liver includes resonances arising most prominantly from phosphomonoesters
(PME), phosphodiesters (PDE), inorganic phosphates (Pi), diphosphodiesters and
nucleosine triphosphates.
Several diffuse liver diseases are characterized by the presence of inflammatory
and fibrotic components. Fibrosis has been shown to be associated with restricted
diffusion of water, diffusion-weighted magnetic resonance imaging (DW-MRI) [26].
However, DW-MRI is sensitive to liver fat and iron [27], and there is incongruity
between studies. For example, Boulanger et al. were unable to demonstrate this
relationship on patients with virus C hepatitis [28]. By assessing mechanical prop-
erties of the tissue transient or ultrasound and magnetic resonance elastography
(MRE) can detect fibrosis [29, 30]. Several studies have reported correlation between
phosphomonoester (PME) resonance (or PME/phosphodiester -ratio) and severity
of liver fibrosis, measured by in vivo 31P MRS and hislogy analysis, respectively
[31, 32]. Recently, it has been suggested that 31P MRS is more sensitive to detect
inflammation or ongoing fibrogenesis rathar than the presence of fibrosis itself [33].
When these MR based methods have been compared, MRE has been shown to out-
perform both DW-MRI and 31P MRS in detecting fibrosis [26, 34]. However, in the
presence of inflammatory activity in the liver, MRE can overestimate fibrosis, and
the effect of these two separate components cannot be distinquished [30].
In addition to monitoring the degree of liver damage, 31P MRS can provide infor-
mation about the functional status of the liver. Moreover, reduced ATP levels have
been found to be associated with obesity [35, 36], type 2 diabetes mellitus (T2DM)
[37] and cirrhosis [38]. Since Pi and exchange in dynamic balance, 31P magnetiza-
tion transfer experiment allows assessment of hepatic adenosine triphosphate (ATP)
synthesis [39]. ATP synthesis has been found to be related to insulin resistance and
reduced in patients with T2DM [40].
Even though, promising results have been reported from both hepatic in vitro
and in vivo 31P MRS studies, clinical applications are rare. Several economical and
technical reasons have kept in vivo 31P MRS in the marginal. Restricted signal-to-
noise ratio and spectral resolution cause reliability and repeatability issues, while
necessary dedicated hardware including separate RF-amplifier and measurement coil
will be a marked extra cost.
41.4 Aim of the thesis
The aim of this thesis was to evaluate the feasibility of the hepatic in vivo 31P MRS
in clinical environment with the equipment available in hospital district of Helsinki
and Uusimaa (HUS), and to provide recommendations for quantification strategy
through analysis of simulated spectra.
In vivo measurements were restricted to single voxel spectroscopy on healthy
subjects only. Absolute quantification with external concentration reference was
not performed. Instead, total phosphorus signal was used as an internal reference in
quantification. As a novel approach in clinical environment, nuclear Overhauser en-
hancement was applied to boost signal-to-noise ratio (SNR) and proton-decoupling
to improve spectral resolution. Other measurement parameters were chosen to keep
measurement time clinically feasible. 1H MRS was performed to exclude possible
fatty liver.
52 Theory of hepatic NMR
In this section, the basics of nuclear magnetic resonance is presented to the extent
required for understanding the present thesis. Unless otherwise denoted, the text is
based on the books of Levitt [41], Tofts [42] and de Graaf [43].
Each atomic nucleus has a physical property called spin, which, however, has
almost no effect on the normal chemical and physical behaviour of substance. The
only requirement for a nucleus to give an NMR absorption is that the nucleus posses
a magnetic moment. Nucleus with spin quantum number I has 2I + 1 energy states.
Thus, nucleus with I 6= 0 has more than one energy states and is NMR active. Rules
of nuclear spins can be summarized in terms of the mass number A and the atomic
number Z as follows:
1. The nuclear spin is half-integer if the mass number A is odd.
2. The nuclear spin is integer if the mass number A is even and the atomic number
Z is odd.
3. The nuclear spin is zero if both the mass number and A and the atomic number
Z are even.
Nuclei with spin I = 1/2 are spherical in shape, have two spin energy states
and have convenient magnetic properties. Isotopes 1H, 13C and 31P are by far the
three most used isotopes in in vivo MRS. All of them have I = 1
2
, all are relatively
sensitive to NMR and, of course, biologically relevant. Also, nuclei with integer
spin like 1H (deuterium) and 14N have applications in the field NMR spectroscopy.
Properties of some of the most important NMR active nuclei are shown in Table 1.
Spin states of the nucleus are quantified, and energy difference (∆E) between
the states is proportional to the strength of the external magnetic field B0
∆E = hf =
hγB0
2π
(1)
where h is Planck’s constant, γ is gyromagnetic ratio and f frequency. Each
nuclear spin possess a magnetic moment which is associated with the angular mo-
mentum of the nucleus. In an external magnetic field, magnetic moment starts to
precess about the magnetic field direction with a frequency proportional to B0:
ν0 =
γ
2π
B0. (2)
This frequency ν0 is called Larmor-frequency and γ is a constant known as gy-
romagnetic ratio characteristic to each nucleus (Table 1).
In an external magnetic field (B0), spins will align parallel (α) or antiparallel
(β) to the B0. The parallel state has lower energy and is slightly more populated
compared to antiparallel state. The difference between the two populations (I =
1/2), α and β, is related to the energy difference by the Boltzmann distribution
Nα/Nβ = e
∆E/kT , (3)
6where k is Boltzmann’s constant (1.3805× 10−23J/K), and T is temperature in
Kelvin. Nα and Nβ are spin populations with parallel and antiparallel alignments,
respectively. According to Equation 3 the difference between high and low energy
populations is only 13 out of ten million 31P nuclei at body temperature at 3.0 Tesla.
This population difference produce a longitudinal net magnetization (M0) along the
main magnetic field B0. A transition from low-energy to high-energy state must be
delivered in packets of ∆E transmitted at Larmor-frequency according to Equation
1. Figure 3 shows an example of energy level diagram for a dipolar coupled two spin
system with zero, single and double quantum transitions.
Table 1: Properties of the selected NMR-active isotopes with non-zero spin number
I. Relative sensitivity to 1H is proportional to the natural abundance and the cube
of the gyromagnetic ratio γ. Values in in the table taken from [44].
Isotope I Gyromagnetic ratio γ Natural Abundance Relative
(MHz T−1) (%) Sensitivity
1H 1
2
42.58 99.985 1.00
2H 1 6.54 0.015 0.00000145
7Li 3
2
16.55 92.58 0.27123
13C 1
2
10.70 1.1 0.00018
14N 1 3.07 99.63 0.001
15N 1
2
4.31 0.37 0.000004
17O 5
2
5.77 0.037 0.00001
19F 1
2
40.06 100.00 0.833
23Na 3
2
11.26 100.00 0.0925
31P 1
2
17.24 75.53 0.066
207Pb 1
2
8.91 22.6 0.002
2.1 Excitation and relaxation
At thermal equilibrium, longitudinal magnetization is a static vector and spins have
no phase coherence in the transverse plane. However, to observe NMR signal, the
longitudinal magnetization is tilted towards or into the transverse plane using a
second magnetic field B1, which oscillates in the RF (MHz) range. These RF pulses
applied at Larmor frequency ν0 excite the spins. Transverse magnetization (Mxy)
rotates about B0 at the Larmor frequency and induces an electromotive force (emf)
in the receiver coil. The amplitude of the induced emf is determined by Faraday’s
law of induction. This induced emf can be amplified and detected as an NMR
7signal. This exponentially decaying time-domain NMR signal oscillating at Larmor
frequency is known as free induction decay (FID).
2.1.1 Relaxation
Relaxation is the process by which the thermal equilibrium of the spin system is
regained after RF excitation: spin populations return to state determined by the
Equation 3 (T1) and phase coherence in the transverse plane is lost (T2). At ther-
mal equilibrium, in the absence of time-varying magnetic fields B1, longitudinal z
component of the magnetization M is constant:
dMz
dt
= 0 (4)
Both x and y components of M are zero and no NMR signal can be detected.
Under the influence of B0 and B1, orthogonal x, y and z components of M can be
described by using the complete Bloch equations [1]:
dMx
dt
= γ [My(t)B0 −Mz(t)B1y]− Mx(t)
T2
(5)
dMy
dt
= γ [Mz(t)B1x −Mx(t)B0]− My(t)
T2
(6)
dMz
dt
= γ [Mx(t)B1y −My(t)B1x]− Mz(t)−M0
T1
(7)
T1 Relaxation
T1 relaxation, also known as spin-lattice relaxation, characterizes the rate at which
the longitudinal Mz component of the magnetization vector exponentially recovers
towards its thermodynamic equilibrium (Figure 1):
Mz(t) = M0(1− e−t/T1), (8)
The recovery is caused by the fluctuating magnetic fields arising mainly from the
motion of the molecules in the neighbourhood of the magnetic moments. Therefore,
the T1 recovery rate is an indicator of the mobility of the molecules.
T2 Relaxation
After perturbation of the magnetic field into the transverse plane, individual isochro-
mats lose phase coherence and the net component of magnetization lying in the
transverse plane dephases, and the detectable signal diminishes. T2- or spin-spin
relaxation characterizes the rate at which the transverse component of the net mag-
netization M0 exponentially decays towards zero (Figure 2, left):
Mxy(t) =Mxy(0)e
−t/T2 , (9)
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Figure 1: Exponential T1 recovery of longitudinal magnetization Mz. In practice,
magnetization is considered to be fully relaxed when t ≥ 5×T1.
Local inhomogeneities within the sample make isochromats to precess slightly
faster or lower. These spatial differences in precession frequencies results spins with
different locations losing their phase coherence and the FID decaying faster than
if the sample were in the homogeneous field. An inhomogeneous B0 introduces
additional dephasing (R′), on top of the natural T2 decay caused by the random
thermal activity of the sample. The time constant for such decay of the FID is
known as T ∗2
1
T ∗2
=
1
T2
+R′, (10)
where R’ (= 1/T
′
2) is an additional relaxation rate term [45].
2.1.2 The dynamics of T1 and T2 relaxations
Relaxation is a complex process involving several competing mechanisms. In prin-
ciple, any molecular interactions which cause additional magnetic fields can affect
relaxation. There are at least five different mechanisms involving the relaxation
process: i) magnetic dipole-dipole interactions, ii) electric quadrupole interactions,
iii) chemical shift anisotropy, iv) spin rotation interactions, v) scalar coupling inter-
actions. Of these, dipole-dipole interactions and chemical shift anisotropy are the
most relevant in this thesis, and are therefore described more in detail.
Bloembergen-Purcell-Pound (BPP) first described the theory of dipole-dipole re-
laxations in 1948 [2]. Dipole-dipole relaxations is normally the dominant relaxation
pathway for spin 1/2 nuclei in solution.
9Figure 2: Monoexponential T2 decay of signal in time domain on the left. In fre-
quency domain (right), spectral line widths are inversely proportional to the T2
constant. Figure is taken from [45].
Dipole-dipole interactions: The most important source of fluctuating magnetic
fields are dipole-dipole interactions. where the magnetic moment of one nucleus
affects to local field of neighbour nuclei in a random manner, due to molecular
tumbling and Brownian motion. The relaxation itself is induced by the frequency
components close to Larmor frequency (exhibited by the fluctuating magnetic fields).
In order to extract the frequency components of the local magnetic field by
Fourier transform, the concept of correlations function G(τ) is introduced. The
correlation function is a measure for the correlation between the local magnetic fields
as time progresses. After longer τ delays the local magnetic field Bloc is drastically
altered due to molecular tumbling and Brownian motion, whereas for short τ the
local magnetic field Bloc will have not changed much. Correlation function is usually
taken as a decaying exponential:
G(τ) = Bloc(τ)Bloc(t + τ) = B
2
loce
−|τ |/τc , (11)
where τC is the correlation time, which roughly corresponds to the average time
for a molecule to rotate over 1 rad. For mobile spins in the solution τc is short, while
for immobile spins τc is several orders of magnitude longer.
The frequency components in the time-domain function can analyzed by Fourier
transformation:
J(ω) =
∫ ∞
−∞
G(τ)e−iωτdτ = 2B2loc
τc
1 + ω2τ 2c
(12)
Resulting function J(ω) in a Lorentzian form, is called the spectral density func-
tion. ω2τ 2c ≪ 1 represents very fast rotational motion (high frequency components),
ω2τ 2c ≈ 1 intermediate rotational motion and ω2τ 2c ≫ 1 slow rotational motion (low
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frequency components). Fast and slow rotational motion emphasize the high and
low frequency components, respectively.
αα
ββ
αβ
βα
w
w0
w2
wS wI
wS
I
Figure 3: Energy level diagram for a dipolar coupled two spin system. WI and WS
are probabilities for single quantum transitions of spins I and S, respectively. W0
and W2 are probabilities for zero and double quantum transitions, respectively.
During relaxation processes, the rate at which the occupancy of the energy lev-
els change with time. Energy level diagram for dipolar coupled two spin system is
shown in Figure 3. Spins are flagged with letters I and S. WI , WS represent tran-
sition probabilities that spin I or S changes energy level, respectively. W0 and W2
correspond to the probability of a zero or double quantum transition. The longi-
tudinal magnetization for each spin is proportional to the difference in population
across the relevant transitions. According to Solomon equations, time dependency
for spins I and S is given:
dIz
dt
= −(W0 + 2WI +W2)(IZ − I0)− (W2 −W0)(SZ − S0) (13)
dSz
dt
= −(W0 + 2WS +W2)(SZ − S0)− (W2 −W0)(IZ − I0), (14)
where I0 and S0 are the Bolzmann equilibrium magnetizations for spins I and
S. The term (W0 + 2WI,S + W2) represents the direct relaxation, while the term
(W2−W0) represents cross relaxation between the spins. The longitudinal relaxation
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is linear combination of two exponentials, caused by direct and cross relaxations.
For two indentical spins with ωI = ωS the recovery of longitudinal ralaxation is a
single exponential and can be simplyfied to
d(Iz + Sz)
dt
= −2(WI +W2)[(IZ + SZ)− (I0 + S0)] (15)
The relation between transition probabilities and the relaxation rate constant
can be found from the classical Bloch equation 8 and the equation 15 as follows:
1
T1
= 2WI + 2W2 (16)
Analytical expression for dipolar longitudinal relaxation was first introduced by
Ionel Solomon in 1955 [46]:
1
T1
=
3
10
γ4h2
4π2r6
(
τc
1 + ω2τ 2c
+
4τc
1 + 4ω2τ 2c
)
, (17)
where r is inter-nuclear distance over which dipolar interactions take place. Cor-
responding expression for the transverse relaxation rate constant is given by [46]:
1
T2
=
3
20
γ4h2
4π2r6
(
3τc +
5τc
1 + ω2τ 2c
+
2τc
1 + 4ω2τ 2c
)
, (18)
From the equations 17 and 18 can be seen that the T2 relaxation is also affected
by low frequency components, which dominate the relaxation in precence of slow
molecular motion. The T1 relaxation is not affected by low frequency fluctuations.
If rotational motion is very fast (ω2τ 2c ≪ 1), T2 equals T1 since:
1
T1
=
1
T2
=
3
2
γ4h2
4π2r6
τc (19)
This situation (ω2τ 2c ≪ 1) is called extreme narrowing limit.
Chemical shift anisotropy (CSA): Later in the thesis, chemical shift will be pre-
sented as a single number. However, more accurate way to representation of the
shielding constant is a 3 × 3 chemical shift tensor, because a chemical shift of the
nucleus depends upon the orientation of the molecule relative to the main magnetic
field direction. The relaxation rate due to chemical shift anisotrophy in the extreme
narrowing limit is given by:
1
T1
=
7
45
γ2B20(σ‖ − σ⊥)2τc (20)
1
T2
=
2
15
γ2B20(σ‖ − σ⊥)2τc, (21)
where σ‖ and σ⊥ refer to shielding parallel and perpendicular to the symmetry
axis of axial symmetry. From these equations can be seen that, in contrast to
dipole-dipole relaxation, T1 and T2 do not equal under extreme narrowing conditions
and relaxation rates (through chemical shift anisotropy) are proportional to the
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square of the main magnetic field. Due to the latter, the chemical shift anisotropy
becomes increasingly important relaxation mechanism as the magnetic field strength
B0 increases.
Electric quadropole moment: 31P, 1H and the other nuclei with spin I = 1/2 have
a spherical charge distribution and thus they do not possess the electric quadrupole
moment. The quadrupolar interaction does not contribute to relaxation when the
quadrupole coupling constant is zero due to molecular symmetry. However, if the
electric quadrupole moment exists for nuclei (for instance 23Na), it usually dominates
the relaxation process.
Spin rotation (SR) relaxation is most significant for small, symmetric molecules
with short correlation times. Relaxation arises from interruption of coherent rota-
tional motion of entire molecule. Motion generates magnetic fields, which can couple
with the nuclear spin. This mechanism has only little effect, for most molecules ob-
served with in vivo NMR.
Scalar relaxation is most commonly observed with quadrupole nucleus (I > 1/2)
having short relaxation times. Usually scalar coupling has a pronounced effect on
T2 relaxation, leading for instance to line broadening in the spectrum of a spin-1/2
nuclei coupled to a quadrupolar nuclei.
2.1.3 Relaxation mechnisms of 31P metabolites
Principal mechanisms for 31P relaxation in vivo are: dipolar, intramolecular and
intermolecular, chemical shift anisotropy, spin rotation, paramagnetic and scalar[47].
Of these, dipolar relaxation and chemical shift anisotrophy described above are the
two major ralaxation mechanisms for 31P MRS [48].
Specific experiments on model solutions indicate that chemical shift anisotropy
(CSA) is the dominant mechanism for relaxation of 31P nuclei in ATP at high
magnetic fields, whereas dipolar interactions dominate the T1 relaxation rate at
lower fields. The reduced T1 relaxation times for
31P NMR at higher field strengths
allow shorter acquisition times or improved SNR per unit of time. However, from
the Equation 21 and Figure 2 we can conclude that if chemical shift anisotrophy
is a dominant mechanism, the line widths increase linearly with B20 , whereas the
frequency range increases according to B0. Therefore, spectral resolution cannot be
infinitely increased by increasing the main magnetic field, and the best resolution is
not obtained at the highest magnetic field.
Dipolar relaxation is always present, CSA is present for nuclei in less than tetra-
hedral symmetry, and SR is likely to be significant for smaller molecules. Param-
agnetic contributions are due to dissolved oxygen and other paramagnetic species.
Scalar contribution is present, when couplings are modulated by exchange or a fast
relaxing partner.
According to several experimental in vivo NMR studies, the transverse relax-
ation rate of ATP is significantly higher than that of other phosphorus containing
metabolites [48]. It is unlike that this large difference is solely based on dipole-
dipole interactions and chemical shift anisotrophy. It has been suggested that short
transverse relaxation time of ATP is partly due to exchange between free and bound
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states of ATP. The strong dipole-dipole interactions between ATP and the unpaired
electron of complexed paramagnetic ion like Mn2+ may also decrease the transverse
relaxation time.
To investigate direct contributions of different 31P relaxation mechanisms In
vivo is challenging. More practical approach is to study metabolites in pure aqueous
solutions in different temperatures at different field strengths. Contributions of intra
and intermolecular dipolar interactions, CSA and SR can be studied monitoring the
T1 as a function of metabolite concentration, B0 field strength and temperature,
respectively.
In a study [47], with aqueous solution Pi showed no field dependence indicating
the absence of CSA contribution, which is expected for tetrahedrally symmetric ions
(Figure 16). For ATP-resonances CSA-contributions are significantly smaller for the
end groups (γ-phosphate), because the shielding anisotropy is less or τc is less due
to the less restricted motion. Andrew and Gaspar measured CSA contributions
of 5% and 34% for γ−ATP at 2.3 Tesla and 7.0 Tesla, respectively, whereas CSA
contributions were significantly higher for α−ATP (14% and 59%) and for β−ATP
(19% and 68%) [47]. Locations phosphates γ, α and β can be seen in in structural
formula in Figure 17.
In an experimental animal study the PDE resonance showed a strong field depen-
dency in relation to other phosphorus metabolites, suggesting dominant contribution
to relaxation via CSA [49]
T1 was found to be independent of concentration in the range of 0.01−0.1 mol,
suggesting that the dipolar relaxation contributions were mainly intramolecular.
Typically T1 values reported in vivo [50, 39] are shorter than values reported for
pure aqueous solutions. This is probably due to small concentrations of paramag-
netic ions, dissolved oxygen and from the presence of large molecules to which the
metabolites become attached for variable residence times [47].
2.2 Data acquisition
2.2.1 Measurement coil
Radiofrequency coils are needed to rotate the longitudinal magnetization to the
transverse plane and to detect the signal induced by the oscillating magnetic field
B1 in the sample. An RF coil can be seen as a LCR circuit, where L is a pure
inductance of the coil and R is a resistance of the wires. The circuit is powered by
the driving electromotive force (emf).
In general, the impedance Z is written in complex notation as Z = R + iX,
where R is resistance and X reactance. According to the Ohm’s law U=ZI, the
current in the coil is inversely proportional to the impedance and thus, in practice,
the impedance is minimised by eliminating the reactive component X with a parallel
capasitor:
ωL− 1
ωC
= 0⇐⇒ ω = ω0 = 1√
LC
, (22)
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where ω0 is the natural frequency of the circuit, ω the applied emf frequency
and C capasitance. RF coil is brought into resonance by adjusting the capasitor C
according to equation 22. This process is usually referred as ’tuning’.
Coil is connected to preamplifier and the rest of the receiver system through
standard coaxial cables with 50 Ω impedance. If the impedance of the RF coil and
the sample differ from 50 Ω, which is usually the case, some of the power will be
reflected according to equation[51]:
ρL =
ZL − Z0
ZL + Z0
, (23)
where ρL is the reflection coefficient, ZL is the impedance towards load and Z0
is the impedance toward the source. If ZL equals Z0, the ρL becomes zero and
no power will be lost due to reflection. To avoid signal losses, RF coil has to be
also matched to 50 Ω in addition to tuning. At a certain off-resonance frequency
ω50Ω the resistance equals 50 Ω plus reactance. This reactance can be nulled with a
second ’matching’ capasitor ´C. After introduction of ´C, the tuning capasitor has
to be readjusted to make ω50Ω the Larmor frequency. Besides ’C, the RF coil is also
possible to match inductively with a separe indutance coil. Tuning and matching
has to be performed for each load individually.
Electric and magnetic interactions exists between the the subject and the RF
coil. These subject-coil interactions are responsible for energy exchange during RF-
pulse transmission and signal reception, and can be studied by quality factor Q. For
the unloaded, tuned and matched RF coil the quality factor Q is:
Qunloaded =
ωL
Rc
, (24)
where Rc is the resistance of the RF coil. For magnetically lossy sample such as
physiological salt solution with the conductivity σ 6= 0, Q value reduces to:
Qloaded =
ωL
(Rc +Rm)
, (25)
where Rm represents the effective resistance to the magnetically induced cur-
rents within the sample. The coil sensitivity is proportional to the
√
Qloaded, thus
maximisation of this value is desirable
There is not a general single coil optimal for all applications. A volume coil
provides a homogenous radiofrequency field (B1 field), resulting in uniform spin
excitation across the sample. However, due to large size and poor filling factor,
the sensitivity of volume coil is often compromised. For surface coils the situation
is opposite: they are very sensitive, but the B1 field is extremely inhomogenous.
Thus, surface coils are desirable for signal reception and volume coils for signal
transmission. In a cost effective clinical environment RF coils for nuclei other 1H
are often single transceiver surface coils combined with adiabatic RF pulses.
In 2010 at the 96th annual meeting of the Radiological Society of North America
(RSNA) in Chicago the first commercially available digital broadband MRI system
was publicly introduced. In this new Philips Ingenia MR system, radiofrequency
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signals are digitized by microelectronics directly in the coil, rather than first trans-
mitted in analog mode through coaxial cables and digitized in a converter.
2.2.2 RF pulses
RF pulses are required for all Fourier transform magnetic resonance imaging (MRI)
and spectroscopy (MRS) experiments. RF pulses are essential for excitation and
inversion as well as primary tool for refocusing of spin populations in MRS. Short,
intense, constant-amplitude pulses are most often used to achieve uniform excitation
of the spins. In a most simple case, when off-resonance effects can be neglected the
nutation angle θ achieved by a RF pulse can be expressed as
θ = γB1T, (26)
where T is the pulse lenght.
However, if the width of spectra is comparable to the applied RF field, the
off-resonence effects cannot be ignored and the magnetization rotates about tilted
effective field Be. The effective magnetic field B[e](t) can be written as
Be = |Be| =
√
B21 +
(
∆Ω
γ
)2
, (27)
where ∆Ω is frequency offset. Therefore, B1 should be replaced by Be in the
Equation 26 in the presence of off-resonance effects.
Many in vivo NMR experiment require more sophisticated RF pulses. B1 mag-
netic field, generated by surface coils, is extremely inhomogenous and RF amplitude
can vary by a factor of 10 over the sensitive volume, when using conventional RF
pulses. This problem is often solved by using so called adiabatic pulses. In principal,
adiabatic pulses are composed of hundreds of closely spaced hard RF pulses with
different amplitude and phase. The overall effect of adibatic pulse is identical to a
single hard pulse, except that adiabatic pulses generate a uniform nutation angle
independent of RF amplitude above a certain threshold value.
In general, adiabatic pulses are referred as amplitude- and frequency-modulated
pulses, but the latter can also be replaced by phase-modulation. Same amplitude-
and frequency-modulations functions can be used for adibatic half (AHP) and full
(AFP) passage pulses. AHP and AFP are used for signal excitation and inversion,
respectively.
2.2.3 Spatial localization
In order to acquire the spectrum from the volume of interest, a suitable localization
method is needed. Point resolved spectroscopy (PRESS) [52, 53], stimulated echo
acquisition mode (STEAM) [54] and image selected in vivo spectroscopy (ISIS) [55]
are the three most common, commercially availabe, volume selection methods [56].
Echo-based PRESS and STEAM dominate proton MRS, while FID-based ISIS is
the most common technique for in vivo 31P MRS due to short T2 relaxation time of
31P metabolites.
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Figure 4 shows the pulse sequence diagram of ISIS sequence. The basic ISIS
sequence employs three frequency-selective inversion pulses in the presence of three
orthogonal magnetic fields Gx, Gy, Gz. Magnetization in a slice defined by the
gradient and 180◦ pulse is inverted. Following the 90◦ excitation pulse this magne-
tization is 180◦ out-of-phase relative to the magnetization elsewhere in the sample,
and relative to the magnetization generated throughout the sample in the second ex-
periment. When zero or even number of 180◦ pulses are executed, the magnetization
ends up along the positive longitudinal axis, whereas during a scan with odd number
of 180◦ pulses, the magnetization ends up along the negative longitudinal axis. Thus,
the 90◦ pulse after even or odd number of 180◦ pulses will excite the magnetization
to positive or negative y axis, respectively. Further, adding and subtracting the in-
dividually stored scans with even and odd number of 180◦ pulses, respectively, will
constructively accumulate signal from the desired locations, while destructively can-
celling signal from all other locations. Table 2 shows how the amount of experiments
with varying 180◦ pulse-gradient combinations affects on signal accumulation.
The number of component experiments required for n-dimensional selection is
2n and thus volume selection requires eight acquisitions. This results in cancellation
of signal outside a cuboidal volume defined by the intersection of the three selected
slices.
Table 2: Experiments 1-8 of ISIS sequence with different gradient combinations
(Gx,Gy,Gz) and corresponding signal accumulation. ON refers to the application
of a selective pulse and OFF to the absence of selective pulse. V is a total volume
without selection, Sn is a slice defined by field gradient along n-axis, Lnm is a bar
(intersection of two slices in orthogonal planes) defined by gradients along n- and
m- axis, and Cnml is a cube defined by gradients along n- m- and l-axis.
180◦/Gx 180
◦/GZ 180
◦/GZ SIGNAL
exp 1 OFF OFF OFF V
exp 2 ON OFF OFF V – 2SX
exp 3 OFF ON OFF V – 2SY
exp 4 OFF OFF ON V – 2SZ
exp 5 ON ON OFF V – 2SX – 2SY + 4LXY
exp 6 ON OFF ON V – 2SX – 2SZ + 4LXZ
exp 7 OFF ON ON V – 2SY – 2SZ + 4LY Z
exp 8 ON ON ON V–2Sx–2Sy–2Sz+4Lxy+4Lxz+4Lyz+8Cxyz
2.3 Magnetic resonance spectroscopy
In this section, the basic sources of fine structure of NMR spectrum is discussed. As
an example the MRS spectrum of ATP is shown in Figure 5.
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Figure 4: Structure of 31P ISIS pulse sequence incorporated with nOe and proton
decoupling.
2.3.1 Chemical shift
When a nucleus is placed in an external magnetic field, negatively charged electrons
will rotate about B0 in an opposite sense to the proton spin precession. Rotating
electrons can be regarded as small currents, giving rise to a magnetic moment µe
at the nucleus. µe opposes the external magnetic field and the effective field at the
nucleus is reduced, thereby leading to a different Larmor frequency:
ν =
γ
2π
B0(1− σ), (28)
where σ is the shielding constant, a dimensionless number, caused by the elec-
trons surrounding a nucleus.
Usually chemical shifts δ are expressed in terms of parts per million (ppm) instead
of Hertz; this expression is independent of the external field strength. Chemical
shifts in ppm are defined as:
δ =
ν − νref
νref
× 106, (29)
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where ν and νref are the frequencies (in Hertz) of the compound under investi-
gation, and of a reference compound, respectively.
By convention, the PCr resonance, albeit not present in the human liver, is used
as an internal chemical shift reference and is assigned a chemical shift of 0.00 ppm.
By a convention in NMR, the chemical shift δ scale always increases from right to
left in plotted spectra.
Without this phenomenon nuclei of the same element in different molecule would
resonate at the same frequency and the NMR spectroscopy would be of minor im-
portance in chemistry, medicine or any other field.
2.3.2 J-coupling
-5 -10 -15
ppm
-ATP
β-ATP
α-ATP
Figure 5: ATP resonances in simulated 31P MR spectra. γ- and α- phosphates are
coupled to β-phosphate only and appear as douplets. β-phosphate in the middle of
the molecule is coupled to both neighbouring γ- and α- phosphates and therefore
its resonance appears as a tripled.
A common feature of NMR spectra is the splitting of resonance into several
smaller lines. This phenomenon is referred to as scalar coupling, J-coupling, spin-
spin coupling, or the indirect dipole-dipole coupling. J-coupling originates from
the magnetic moments, which can influence each other through indirectly through
chemical bonds. As a contrary to dipolar coupling, interactions through chemical
bonds will not average out, but give a rise to the J-coupling. The J-coupling con-
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stant rapidly decreases with increasing number of chemical bonds. J-coupling can
be typically ignored for four or more bonds. Unlike chemical shift, J-coupling is
independent of the applied external magnetic field B0 and therefore always specified
in Hertz.
In 31P NMR, homonuclear 31P-O-31P interactions stretch over two bonds, while
heteronuclear 1H-31P interactions stretch over one bond only. When the frequency
difference |νA − νB| between two J-coupled spins A and B is much larger than the
coupling constant JAB between them, the splitting pattern can be predicted from
the Pascal’s triangle, which is shown in Table 3. This condition, |νA − νB| ≫ JAB,
is certainly valid for heteronuclear J-coupling. However, for many homonuclear
interactions the frequency difference |νA−νB| is the same order of magnitude as the
J-coupling constants JPH, giving rise to a so-called strongly coupled spin systems.
Magnetically equivalent nuclei do not produce observable splitting. Figure 5 shows
an example of J-coupling of ATP.
Table 3: Pascal’s triangle, used for splitting patterns between J-coupled spins.
No. of neighbors relative intensities pattern
0 1 singlet
1 1 1 doublet
2 1 2 1 triplet
3 1 3 3 1 quartet
4 1 4 6 4 1 pentet
5 1 5 10 10 5 1 sextet
At B0 of 3.0 Tesla, the frequency differences of ATP resonances |νγ − νβ| and
|νβ−να| are approximately 28Jγβ and 45Jβα, respectively. Therefore ATP-resonances
can be considered as a weakly coupled spin system. The three-bond heteronuclear
J-couplings for the PME and PDE resonances are in the 6–7 Hz range and lead to
undesirable line-broadening. Line-broadening induced by heteronuclear J-coupling
can be eliminated by heteronuclear decoupling, which will be discussed later in more
detail.
Typical magnitudes of scalar coupling constants are: 1H-31P, 10−20 Hz; and 31P-
O-31P, 15−20 Hz [57]. J-coupling phenomenon can be efficiently utilized in in vitro
NMR spectroscopy experiments giving us information about molecular structures.
2.3.3 Proton-decoupling
The J-splittings distribute the signal intensity over many smaller peaks. These mul-
tiplet structures decrease the spectral resolution as the spectrum is crowded and
more difficult to interpret. Moreover J-coupling decreases signal-to-noise ratio and
therefore makes it undesirable phenomenon in in vivo NMR spectroscopy. For exam-
ple, in hepatic 31P MRS, separation of heteronuclearly coupled (31P-1H) PME and
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PDE resonances into their subcomponents is impossible at clinical field strengths of
1.5-3.0 Tesla. However, occasionally well known multiplet structures can be used for
resonance recognition [58]. In hepatic 31P spectra α− and γ−ATP resonances have
a doublet structures, while the phosphorus nuclei at the center of the triphosphate,
β−ATP, has a triplet structure. These couplings of ATP resonances are homonuclear
of nature , since nuclei are coupled to neighboring phosphorus.
35 30
ppm
35 30
ppm
a) b)
Figure 6: An example of 31P MR spectra a) without and b) with proton-decoupling.
Spectra are measured on a 10 cm diameter phantom sphere containing 313 mM
methylphosphonic acid [P(OH)2O(CH3)]. Phosphorus nucleus is coupled to three
methyl protons with JPH of 17.24 Hz and the signal is splitted to quartet. By apply-
ing a proton-decoupling scheme to the measurement sequence, multiplet structure
disappears and SNR is greatly improved.
The heteronuclear coupling effects discussed above can be removed by applying
a proton decoupling scheme to the measurement pulse sequence. In this proton
decoupling scheme, protons are irradiated during the 31P acquisition. Figure 6
demonstrates the effect of decoupling scheme on spectral appearence.
Nuclear Overhauser enhancement and heteronuclear decoupling schemes can be
incorporated into ISIS sequence as shown in Figure 4.
For phosphomonoesters, phosphodiesters, and ATP, the predominant phosphorous-
proton J-coupling is to -O-CH2 methylene protons, which resonate at 4.3 ppm to
3.8 ppm.
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2.3.4 Nuclear Overhauser effect
The nuclear Overhauser effect (nOe) requires the presence of two non-indentical
spins and is closely related to magnetic dipolar interactions. For heteronuclear ex-
periments, nuclear Overhauser effect generates useful enhancement in signal inten-
sity of the low-sensitivity nucleus upon the saturation of the protons. Enhancement
is brought about by 1H irradiation before the start of each experiment.
ǫNOE = 1 +
γ1H
γ31P
W2 −W0
W0 + 2W31P +W2
= 1 + η, (30)
where W2 and W0 are transition probabilities for double and zero quantum tran-
sitions, respectively. W31P is transition propability for phosphorus spin.
Theoretical maximum of ǫNOE is achieved with very rapid molecular motion in
extreme narrowing limit (ω2τ 2c ≪ 1):
ǫNOE = 1 +
γ1H
2γ31P
= 1 + η, (31)
where η is usually called nuclear Overhauser enhancement.
In theory, the maximal nOe for 31P-1H is 2.235, but the maximum η occurs in
the extreme narrowing limit if the only relaxation mechanism is dipolar coupling.
In practice, dipolar interactions account only for a part of all relaxation mechanism
and thus typical nOe values with in vivo applications are 1.4-1.8 for 31P-1H [48].
The NOE factors for the metabolites are not all the same. It has been shown
that T1 values correlate with NOE enhancement (η). Metabolites, sensitive to
relaxation mechanisms other than dipolar interactions, have shorter T1 and smaller
η. Estimated NOE enhancement, by Li et al. [59], for liver metabolites at 1.5 Tesla
are shown in Table 4. However, enhancement is expected to be smaller at 3.0 Tesla,
where weighting of CSA as a relaxation mechanism increases.
2.4 Processing of the NMR signal
NMR signals can be prosessed and quantified either in a time or a frequency domain.
Typically, signals are preprocessed prior to quantification in order to correct the
signal phase or baseline, reduce noise, improve the spectral resolution and suppress
unwanted resonances. These analysis steps are discussed in the following sections.
2.4.1 Zero filling
The spectral resolution ∆v of a NMR spectrum is SW/N, where SW is spectral
width, N the number of sampled points and also inversely proportional to the sam-
pling time Tacq:
∆v =
1
Tacq
=
1
Nδt
, (32)
where δt is the time interval between two successive sampling points. Thus,
spectral resolution can be improved by increasing the acquisition time or decreasing
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Table 4: Estimated contributions of nOe (η) for each metabolite in hepatic 31P NMR
spectra at 1.5 Tesla by Li et al. [59]
.
Compound NOE
Phosphoethanolamine (PE) 0.30
Phosphocholine (PC) 0.47
Inorganic phosphates (Pi) 0.17
Glycerophosphoethanolamine (GPE) 0.59
Glycerophosphocholine (GPC) 0.73
Phosphoenylpuryvate (PEP)/phosphatidylcholine (PtdC) 0.34
Adenosine triphosphate (α-ATP) 0.36
Adenosine triphosphate (γ-ATP) 0.21
Adenosine triphosphate (β-ATP) 0.21
Nicotinamide adenine dinucleotide phosphate (NADPH) 0.55
the spectral width. However, in order to avoid aliasing, Nyqvist-Shannon sampling
theorem set limits to minimum spectral width, and, on the other hand, increase of
acquisition time will lead to an increase of relative noise contribution. Similar effects
can be achieved through signal processing. An operation of adding a string of time
points with zero amplitude to the FID, prior to Fourier transformation is known as
zero filling. This operation simulates extending of the acquisition time. Zero filling
does not increase the information content of the data, but it can greatly improve
the spectral appearance as shown in Figure 7.
As an opposite to zero filling, few first points of the FID can be be removed
before Fourier transform. This can be used to suppress wide spectral resonances
with very short T2.
2.4.2 Time domain filtering
Spectral apodizing can be used for line broadening or noise reduction. In order to
optimize SNR, optimal line broadening to use is the line width at half maximum
(LWHM). Increasing the width of the window function, will reduce spectral resolu-
tion. Typical window functions used in in vivo MR spectroscopy include Hamming,
Hann, Gaussian and exponential functions. Exponential weighting is done by mul-
tiplying FID with a following function:
f(t) = e−t/Tw , (33)
where Tw (> 0) is a time constant, which determines the steepness of the de-
cay. Filter function f(t) will enhance the data points at the beginning of the FID.
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Figure 7: Effect of zero filling on spectral resolution. With spectral resolution of 9.77
Hz, triplet structure of β-ATP is not well resolved. Zero filling the original spectra
prior to Fourier transform by factors 2, 4, 8 and 16 leads to spectral resolutions
of 4.89, 2.44, 1.22 and 0.61 Hz, respectively. Triplet structure is already resolved
after zero filling by factor of 2, but no further improvement in spectral resolution is
observed by increasing the factor above 4. Figure taken from [57].
whereas, the end parts of the FID, where noise is dominating, will be damped and
the SNR of the spectrum is enhanced. Tw of 200 ms corresponds 5 Hz.
Theoretically predicted Lorentzian lineshape has longer ’tails’ than Gaussian
lineshape. If an accurate determination of overlapping resonance lines is required,
it might be advantageous to convert Lorentzian NMR lineshape to more narrow
Gaussian lineshape:
f(t) = et/TLe−t
2/T 2
G , (34)
where TL and TG are time constants for Lorentzian and Gaussian filtering, re-
spectively. Lack of negative sign in the exponent of the first term will decrease the
Lorentzian part of the FID, while the second term increases (assuming that TG > 0)
the Gaussian character of the FID.
Figure 8 shows clear improvement in noise reduction in hepatic in vivo 31P MR
spectrum, where LWHMs for GPC and GPE are 9˜-10 Hz due to apodization with
different Lorentzian filters.
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Figure 8: In vivo 31P MR spectrum of the human liver a) without spectral apodiza-
tion and with spectral apodization with Lorenzian filters of b) 10 Hz, c) 20 Hz and
d) 30 Hz.
2.4.3 Fourier transform
Fourier transform does not enhance the information content, but makes the infor-
mation in the signal more visible for the human eye. Both time domain signal s(t)
and the spectrum S(ω) are complex functions. While time-domain signal is a su-
perposition of oscillating components, the spectrum is a superposition of Lorentzian
spectral components. The imaginary part of the complex Lorentzian function is
called the dispersion Lorentzian:
S(ω) =
ω − ω0
λ2 + (ω − ω0)2 , (35)
where ω0 is the angular Larmor frequency, ω the frequency coordinate and λ is
a peakwidth parameter. The real part of the complex Lorentzian is called the
absorption Lorentzian:
S(ω) =
λ
λ2 + (ω − ω0)2 . (36)
Since absorption Lorentzians have better resolution than dispersion Lorentzians,
only the real part of spectrum is usually displayed (Figure 9). The parameter λ is
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called the coherence decay rate constant equal to the inverse of transverse relaxation
rate constant T2
λ =
1
T2
(37)
From the Equations 37 and 36 above can be seen that resonances with fast and
slow signal decay will lead to a broad and narrow spectral peaks, respectively. In
practice Fourier transforms are calculated using an efficient numerical algorithm
called the fast Fourier transform (FFT) [60]. An important limitations of FFT is
that a number of Fourier-transformed points must be an integer power of 2.
Figure 9: Absorption Lorentzian (black line) and dispersion Lorentzian (red line)
2.4.4 Phase Correction
Macroscopic motion can lead to zero order phase changes. Phase changes do not
necessary lead to signal loss per se, but it can be problem at case of extensive signal
averaging of spectra with different phases. Phase correction prior to signal averaging
is therefore highly recommended.
usually phase correction is performed according to:
ϕ(ω) = ϕ0 + ϕ1ω, (38)
where subscripts 0 and 1 indicate zero (constant) and first order phases, respec-
tively. ϕ0 is constant phase correction for all resonances in the spectra and ϕ1 is a
linear, frequency dependent phase correction. Figure 10 shows an example of the
effect of phase correction on spectrum appearance.
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a)
b)
Figure 10: The effect of signal phase on spectral appearence: a) dephased simulated
31P MR spectrum and b) same spectrum corrected for first and second order phases.
If the first points of a time domain signal were truncated, this has an influence
on the first order phase or begin time of the signal that has to be corrected.
2.4.5 Quantification
Instead of reporting signal intensities in voltage or arbitrary units, in vivo NMR
spectra can be used to derive absolute concentrations, expressed in mmol/L or
µmol/g of tissue. This originates from the fact that net magnetization M0 is di-
rectly proportional to the number of spins, which is proportional to the molar con-
centration. However, in MRS experiment, M0 is not detected directly but rather an
induced current proportional to the transverse magnetization. The induced signal
SM from a metabolite M detected in a receive coil is depended of several factors as
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follows:
SM = NS × RG× ω0 × [M ] × V × fsequence × fcoil, (39)
where NS represents number of scans, RG receiver gain, ω0 Larmor frequency and
V volume. Sequence factor (fsequence) depends on the TE, TR, spatial localization
method, as well as T1 and T2 of the measured metaboliteM . Coil factor fcoil depends
on the qualities of the RF coil e.g. quality factor Q, filling rate and geometry of the
coil.
Several methods exist for quantification of metabolite in NMR spectroscopy.
These can roughly be divided in time or frequency domain methods. In this thesis,
a model based approach called AMARES was used. Other methods such as peak
area integration in frequency domain are only briefly described.
Integration of the peak area is the most straightforward method to calculate peak
intensities in the frequency domain, but it is not suitable for overlapping peaks. In
addition, it cannot take tails into account and thus intensities are systematically
underestimated. Figure 11 demonstrates the determination of γ-ATP intensity by
integration.
Figure 11: The intensity of γ-ATP determined by integration between vertical
dashed lines in phase corrected spectrum.
Prior knowledge of relations between model parameters decreases the Cramer-
Rao bounds (CRB) and consequently increases the precision. Partially overlapping
resonances cannot be separated by integration.
2.4.6 Error estimation
Error estimation is an important part of metabolite quantification. If noiseless data
can be exactly modelled, measured data xi can be expressed as
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xi = xˆi + bi, (40)
where xˆi is model function and bi Gaussian distributed noise [61]. Evaluation
of the CRLBs requires inversion of the Fisher information matrix F , which can be
expressed as
F =
1
σ2
ℜ(P TDHDP ), (41)
where σ is the standard deviation of real and imaginary parts of the noise, ℜ refers
to real part. T and H are transposition and Hermitian conjugation, respectively.
The matrix D contains the partial derivatives of the model function xˆi with respect
to the parameters pj in the vector p:
Dij =
∂xi
∂pj
(42)
The prior knowledge matrix P can be expressed as:
Pmn =
∂pj
∂p
′
k
, (43)
where pk corresponds to the unconstrained parameters pj to be estimated. Incor-
poration of prior knowledge reduces the number of free parameters and consequently
the size of information matrix F.
The CRBs on the standard deviations of the estimated parameters are given by
the fundamental Crame´r-Rao inequality, which is obtained from inverting the Fisher
matrix as follows:
σpi ≥ CRLBpi =
√
F−1ii (44)
Precision of the quantification cannot supersede the CRLBs, but small CRLB is
not a guarantee for an accurate metabolite concentration.
2.5 The liver and 31P metabolites
In this section, anatomy and physiology of liver is first described. Further, metabo-
lites visible in hepatic in vivo 31P MR spectroscopy are presented.
2.5.1 Liver anatomy
Liver consists of four anatomically distinct lobes shown in Figure 12: the right, left,
quadrate and caudate lobes in an ascending size order.
In a histological scale, liver consists of functional units called liver lobules. These
lobules are formed by paranchymal and nonparenchymal cells. Parenchymal cells
called hepatocytes occupy approximately 80 % of the total liver volume. They per-
form most of the numerous liver functions. Nonparenchymal cells, locating in the
sinusoidal compartment of the tissue, consist of three different types of cell types:
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Figure 12: Anatomy of the liver. Picture taken from [62].
Kuppfer cells, sinusoidel endothelial cells and hepatic stemmate cells. Nonparenchy-
mal cells represent 40 % of the total number of cells in the liver, but contribute only
6.5 % of the total liver volume [63].
A whole network of various sized ducts branch through the liver. This structure
is known as a biliary tree and it has an important role in transporting the bile.
Bile, needed for digestion of food, contains water, electrolytes and organic molecules
including bile acids, cholesterol, phospholipids and bilirubin. Bile is produced in
hepatocytes and it drains into microscopic canals known as bile canaliculi. These
bile canaliculi join together into larger bile ducts known as canals of Hering, from
which the path goes as follows in ascending order of the duct size: interlobular bile
ducts, intrahepatic bile ducts, and left and right hepatic ducts, which merge to form
the common hepatic duct that exits the liver and joins cystic duct. The structure
of the biliary tree, excluding smaller structures, is shown in Figure 13.
Compared to other organs, liver has a unique, dualistic, blood supply system.
Oxygeneted blood is provided by hepatic arteries, just like for any other organ, but
it represents only one third of the total blood supply of the liver. Two thirds of
the blood is provided by the hepatic portal vein, which carried nutrient-rich venous
blood drained from spleen, stomach, pancreas, gallbladder and intestine. The liver
receives 25 % of the cardiac output even though it constitutes only approximately
2.5 % of the body weight, and the hepatic parenchymal cells are the most richly
perfused of any of the organs [65].
Right liver lobe is the most obvious target for volume of interest in single voxel
spectroscopy. It is 5 to 6 times larger and less sensitive to cardiac motion as com-
pared to the left lobe. Liver steatosis has been reported to be greater in the right
than in the left lobe, but generally the lobar variability of the steatosis is low [66].
Therefore, the right lobe is a primary target for monitoring liver metabolism.
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Figure 13: Biliary tract. Figure modified from [64]
2.5.2 Liver physiology
Liver has numerous important functions in human physiology such as ingestion,
metabolism, detoxification, storage, production and immunity.
Moreover, liver has a critical role in metabolism of different energy sources. In
maintenance of normal blood glucose levels, excess postprandial glucose entering
the blood is taken up by the liver and sequestered and stored as a glycogen in a
process called glycogenesis. When glucose levels in blood begin to decline glycogen
is depolymerised into glucose and exported back to blood. When glycogen reserves
become exhausted glucose can be synthesized in the liver from e.g. amino acids in
a process called gluconeogenesis.
In fat metabolism, liver is active in oxidizing triglycerides to produce energy.
Liver synthesises fatty acids from excess carbohydrates in a process known as de novo
lipogenesis. Also, large quantities of cholesterol and phospholipids are synthesised
in the liver.
Liver takes part in protein metabolism by synthesising i) most of the plasma
proteins, ii) non-essential amino acids and iii) clotting factors necessary for blood
coagulation. Liver also removes toxic ammonium from circulation by synthesising
urea.
In digestion of fat, liver produces bile, which helps emulsification of fats for
absorption of fatty acids.
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Table 5: Chemical shifts and coupling constants of relevant 31P containing metabo-
lites in the human liver [67, 68]
Compound Shape Chemical shift J-coupling
(ppm) (Hz)
Phosphoethanolamine (PE) singlet -
Phosphocholine (PC) singlet 5.88 -
Inorganic phosphates (Pi) singlet 5.02 -
Glycerophosphoethanolamine (GPE) singlet 3.20 -
Glycerophosphocholine (GPC) singlet 2.76 -
Phosphoenylpuryvate (PEP) singlet 2.06 -
Adenosine triphosphate (α-ATP) doublet –7.52 15.5-19.5
Adenosine triphosphate (γ-ATP) doublet –2.48 15.5-19.5
Adenosine triphosphate (β-ATP) triplet –16.26 15.5-19.5
Nicotinamide adenine dinucleotide
phosphate (NADPH) singlet -8.30 -
In addition, liver clears blood of drugs and other (harmful) substances like alcohol
and helps immune system by producing immune factors and removing bacteria from
the bloodstream.
Dispersion of the phosphates found in vivo is relatively large - approximately
30 ppm - which makes spectral resolution sufficient to distinquish most of the key
metabolites at clinical field strenghts (≤ 3.0 T). In a standard clinical environment
with standard sequencies, 31P MRS detects relatively few spectral signals. These
resonance singnals are phosphomonoesters (PME), inorganic phophate (Pi), phos-
phodiesters (PDE), nucleoside triphosphate (γ-NTP), α-NTP, β-NTP. All of these
signal names by themselves do not necessarily carry descriptive value in biochem-
istry, physiology, or pathophysiology. Rather, they represent a heterogenous mix of
compounds that share a common chemical feature (i.e. phosphomono- or phospho-
diester bond)[69].
2.5.3 Phosphomonoesters
According to in vitro NMR studies at high field strenghts (11.7 Tesla), phospho-
monoester region of the hepatic in vivo MR spectrum contains over 10 overlapping
resonances including signals from adenosine monophosphate (AMP) [71], Phospho-
ethanolamine (PE), Phophocholine (PC), coenzyme A, 2,3-diphosphoglycerate (2,3-
DPG), and intermediates of carbohydrate metabolism such as glucose 6-phosphate,
glycerol 1-phosphate, 3-phosphoglycerate, and ribose 5-phosphate (Figure 14b). Fig-
ure 15 shows a PME region of the high-resolution in vitro spectra of human liver
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Figure 14: In Vitro 31P NMR spectrum at 121.4 MHz of perchloric acid liver ex-
tract of A) healthy rat and B) expanded view between 5.5 and 2.5 ppm. Metabo-
lites: 1, glucose-6-phosphate; 2, sn-glycerol 3-phosphate; 3, coenzyme A; 4, fructose
6-phosphate; 5, Phosphoethanolamine; 6, adenosine monophosphate; 7, NADPH;
8, 2,3-diphosphoglycerate; 9, phosphocholine; 10, inorganic phosphate; 11, glyc-
erophosphoethanolamine; 12, glycerophosphocholine; 13, γ-NTP, 14, β-ADP; 15,
α-ADP; 16, α-ATP; 17, NADPH; 18, UDP-glucose; 19, β-NTP. Edited from the
paper by Harvey et al. [70]
extracts. Excluding PE and PC, most of these metabolites are unstable with is-
chaemia and their concentrations can change by ischemic periods up to one hour.
These ischaemia sensitive metabolites cannot be studied in vitro. PME metabolites,
in particular PC and PE, are believed to represent phospholipid cell membrane pre-
cursors [69]. PE and PC represent 7 and 24 % of the total lipid composition of liver
plasma membrane, respectively [72]
2.5.4 Phosphodiesters
Phosphodiesters (PDE) refer metabolites with phosphodiester bond. In the human
liver PDE region contains two major resonances: glycerophosphocholine (GPC) at
3.20 ppm and glycerophosphoethanolamine (GPE) at 2.76 ppm. Both of these are
thought to represent cell membrane degradation products [69].
2.5.5 Inorganic phosphates
Inorganic phosphate (Pi), shown in Figure 16, is a small and symmetric molecule.
It resonates as a singlet between phosphomonoesters and phosphodiesters at 5.02
ppm. Inorganic phosphates are released by the hydrolysis of ATP and ADP or other
nucleoside diphosphates and triphosphates.
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Figure 15: In Vitro 31P NMR spectrum of the sample from human liver measured
at 11.7 Tesla. Downfield side (ppm ≤ 2.00) of the spectrum has been excluded from
the original figure [73].
In in vivo MRS, the quantification of Pi, is hampered by partly overlapping
resonances of PME and PDE, and wide underlying resonance from motion restricted
phospholipids and vesicle bilayers [74, 75, 76].
The chemical shift of Pi is sensitive to pH and therefore the chemical shift of Pi
can be used to calculated pH by utilizing Henderson−Hasselbach equation :
pH = 6.75 + log
(
δ − 0.75
3.35− δ
)
, (45)
where δ is the chemical shift in ppm for the Pi resonance [67].
2.5.6 Phosphoenolpuryvate and phosphatidylcholine
A small resonance usually seen in in vivo liver NMR spectra on upfield side of
PDE at 2.06 ppm, has been conventionally assigned to phosphoenolpuryvate (PEP)
[77, 78]. PEP is an important chemical compound, which is involved in glycolysis
and gluconeogenesis. The conversion of PEP to ADP by puryvate-kinase generates
one molecule of puryvate and one molecule of ATP. Reversed phophorylation of
puryvate to PEP by phosphoenolpyruvate-carboxykinase is considered to be a rate-
limiting step in gluconeogenesis [79]. However, it has been suggested that intrahep-
atic 31P MRS signal at 2.06 ppm may represent both intrahepatic phosphatidyl-
choline (PtdC) and phosphoenolpuryvate [80]. PtdC is a typical phosphodiester
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Figure 16: Tetrahedrally symmetric Pi molecule
and part of bile lecithin. PtdC synthesis is essential for secretion of very low density
lipoproteins (VLDL) from the liver. Chemical shift of PEP has a strong dependence
on the pH, while the chemical shift of PtdC is pH-independent. According to titra-
tion curve of PEP shown in paper by Chmel´ık et al. [81] , PEP would resonate at
2.06 ppm in an environment with pH of approximately 7.5.
2.5.7 Nucleoside triphosphates
Nucleoside triphosphate (NTP) include α, β and γ signals as shown in Figure 18.
Resonance of α-NTP appears as a doublet at -7.52 ppm, β-NTP as a tripletat -
Figure 17: A structural formula of the nucleoside triphospate (NTP) molecule.
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16.26 ppm and γ-NTP as a doublet at -2.48 ppm. Homonuclear coupling constants
for NTP resonances are shown in Table 5.These nucleoside signals are commonly
referred as ATP signals, although cytosine (CTP), guanosine (GTP), inosine (ITP)
and uridine (UTP) triphosphates contribute to these signals more or less. In vitro
studies suggest that ATP represents approximately 80 % of the total nucleoside
triphosphate content in the rat liver [82]. On the other hand some ATP, less than
10 %, may not MRS visible due to binding to membranes or macromolecules, asso-
ciation to paramagnetic molecules or microviscosity [83].
Figure 18: Hepatic 31P MR spectrum averaged from six healthy valunteers. PE,
phosphoethanolamine; PC, phosphocholine; Pi, inorganic phosphates; GPE, gl-
yserophosphoethanolamine; GPC, glycerophosphocholine; PEP/PtdC, phospho-
enolpuryvate/phosphatidylcholine; γ-NTP, γ-nucleosidetriphosphate; α-NTP, α-
nucleosidetriphosphate; NADPH, nicotinamide adenine dinucleotide phosphate;
UDPG, uridine diphosphate glucose; β-NTP, β-nucleosidetriphosphate.
2.5.8 Diphosphodiesters
In a high resolution 31P NMR spectra of liver extracts from rats, there is a group
of peaks centred at 10.4 ppm. This group of peaks is defined as a diphosphodiester-
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region having contributions from all forms of nicotinamide adenine dinucleotides:
NAD, NADH, NADP, NADPH. Another group of diphosphodiester resonances is
centred at 12.0 ppm including uridine diphospho glucose (UDPG) [70].
2.5.9 Other metabolites and contamination from non-hepatic tissue
Vascular volume of the human liver is approximately 25 % [84], which makes contam-
ination from blood practically impossible to avoid. Erythrocyte 2,3-diphosphoglycerate
(2,3-DPG) resonates at 3,8 ppm and 2.8 ppm thus overlapping with Pi and PME.
Occasionally, a small phosphocreatine resonating at 0.0 ppm can be seen in a hepatic
31P MR spectra. Usually, this has been considered extra-hepatic contamination due
to poor localization. However, it has been also suggested that small quantities of
PCr is present in normal human liver [85]
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Table 6: Parameters used for simulated 31P MR spectra. A denotes amplitude;
α Lorenzian damping factor; β, Gaussian damping factor; f , frequency (chemical
shift). Zero order phase ϕ0 and begin time t were both fixed to 0 for all peaks
Peak (nr) A α (Hz) β (Hz) f (Hz)
1 1.2 30 0–50 327
2 1.1 30 0–50 304
3 2.8 30 0–50 260
4 2.8 30 0–50 166
5 3.5 30 0–50 143
6 1.4 30 0–50 106
7 1.85 30 0–50 -118
8 1.85 30 0–50 -138
9 1.9 30 0–50 -355
10 1.9 30 0–50 -375
11 1.1 30 0–50 -429
12 0.5 30 0–50 -512
13 0.95 30 0–50 -820
14 1.9 30 0–50 -840
15 0.95 30 0–50 -860
3 Experiments
Experiments consist of simulations and actual human measurements. Simulated
spectra were constructed to study the effect of spectral noise and line broadening
on the reliability of signal quantification.
3.1 Simulations
31P MR spectra were simulated using simulation tool implemented in jMRUI v3.0
software [86]. Relative concentrations for PE, PC, Pi, GPE, GPC, PEP, γ-ATP, α-
ATP, NADPH and β-ATP were derived from the paper by Li et al. [59]. In addition,
UDPG resonance was added. Chemical shifts (frequencies), coupling constants, and
relative concentrations are shown in Table 5. Broad baseline resonance in phospho-
diester region was not modelled. Example of simulated spectra are shown in Figure
19.
Each of 15 signal components, shown in Table 6, were created using following
equation:
x(t) = Ae−α−(βt)
2
ei(2pift+ϕ0), (46)
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where A represents signal amplitude (concentration), and α and β Lorentzian and
Gaussian damping factors, respectively. Both, zero (ϕ0) and first (begin time, t)
order phases were set to 0.0 for each resonance. Transmitter frequency was set to
51.72 MHz, which corresponds the Larmor frequency of 31P nucleus at 3.0 Tesla.
Simulated spectra consisted of 4096 data points over the bandwidth of 3000 Hz. The
variable α was set to 30 Hz and the value of β was varied in order to demonstrate
the effect of inhomogeneous broadening.
In order to compare the performance of two fitting approach in the presence of
random noise, 20 Monte Carlo simulations (α = 30 and β = 30) with with 6 different
noise levels (5, 10, 15, 20, 30 and 50%) were generated. These simulations were
quantitated with Gaussian and Lorentzian lineshape fits. Average concentrations
and coefficients of variations were determined.
Random noise with varying RMS amplitude was also added in order to test and
demonstrate the effect of noise to reliability of the quantifications methods.
According to Equation 36, when simple monoexponential decay is expected res-
onance lineshapes are purely Lorentzian. However, this not the case in real life
in vivo measurements. Residual eddy currents, magnetic field inhomogeneity and
multi-exponential relaxation make line shapes more complex in vivo.
3.2 Measurements
All measurements were performed on a 3.0 Tesla (Achieva, Philips, Best, Neather-
lands) clinical imager (Figure 20).
Phosphorus signals were measured using a 31P transmit-receive loop coil with
diameter of 14 cm (Figure 21). The system integrated body coil was used for proton
decoupling and NOE irritation.
3.3 In vivo measurements
We measured 6 (one male) healthy subjects after an overnight fast. Three subjects
were measured twice in separate occasion in order to determine inter-individual
reproducibility.
A circular, non-flexible 31P transmit-receive loop coil with a diameter of 14 cm
(P-140) was placed laterally over the liver, parallel to the main magnetic field B0.
The coil placement was checked with the localizers and repositioned if necessary.
The 1H body coil was used to collect T1-weighted ultrafast gradient-echo images
with repetition time (TR), echo time (TE) and flip angle of 8 ms, 2.3 ms and 15◦,
respectively. Images were collected in three orthogonal directions with 10 mm slice
thickness covering the whole liver in all directions. Image acquisition was performed
in an end-exhalation by instructing the subjects to breath in, breath out and the
hold their breath. Duration of each breath hold was approximately 20 seconds.
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Figure 19: The panel of six simulated spectra demonstrates the effect of Gaussian
broadening on spectral resolution and signal-to-noise ratio (peak hights). Reso-
nances were simulated according to Equation 46. Lorentzian dumping factor (β) of
a) 0 Hz, b) 10 Hz, c) 20 Hz, d) 30 Hz, e) 40 Hz, f) 50 Hz were used. More detailed
simulation parameters are presented in Table 6.
3.4 31P MRS acquisition
A 6× 6× 6 cm3 voxel was placed in the center of the right liver lobe to avoid signal
contamination from the surrounding tissues according to Figure 22.
A total of 2048 data points were acquired in 682 ms over a 3000 Hz receiver band-
width resulting a spectral resolution of 1.46 Hz/point. The ISIS volume selection
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Figure 20: Experiments were performed on a 3T clinical imager installed in Meilahti
hospital.
method was used for 3D spatial localization with a TR of 6000 ms and 128 acquisi-
tions. The more detailed structure of the ISIS sequence used in this experiment is
shown in Table 2.
Spatial variation of B1 associated with a transmit-receive surface coil was com-
pensated by using frequency modulated adiabatic pulses. A hyperbolic-secant based
adiabatic half-passage pulse (HS-EX) was used for the excitation, and the slice selec-
tion was carried out by using a hyperbolic-secant inversion pulse (HS). For the P-140
coil used in this experiment B1max is set to 60 µT. To maximise the bandwidth, both
pulses were time scaled such that their maximum B1 matched the B1max of the coil.
Resulting pulse lengths T for the HS inversion and HS-EX detection pulses are 4.22
ms and 5.42 ms, respectively. These pulse lengths correspond to bandwidths of 57.0
ppm (2.95 kHz) and 22.2 ppm (1.15 kHz) for HS and HS-EX pulses, respectively.
As mentioned above, proton decoupling was provided by the body coil and exe-
cuted in broadband mode, which uses WALTZ-4 phase cycling. Decoupling power
level was set to 400 W and the decoupling frequency was set to −100 Hz from the
water, which corresponds to the chemical shift of 3.9 ppm. The proton decoupling
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Figure 21: 31P MRS loop coil was used for data acquisition. Loop diameter (d) is 14
cm. Long rods were used for tuning the frequency (a) and matching the impedance
(b).
is switched on during the data acquisition time and is switched off during all other
parts of the sequence as shown in Figure 4.
WALTZ-4 pulses were used for broadband irradiation prior to data acquisition
period in order to improve signal gain through NOE. Duration of the irradiation
also known as NOE mix time was set to 3500 ms. We used −100 Hz NOE offset
frequency, similar to decoupling frequency, and NOE power level of 90 W.
Respiratory motion was controlled by instructing the subjects to adjust their
breathing cycle to the pulse sequence noise, so that the excitation and pulse and
data acquisition were timed to end exhalation. Respiratory triggering by using
navigator belt, was not used as it would have been led to intolerable acquisition
times or variable T1-weighting.
3.4.1 Shimming
Automatic pencil beam (PB) shimming was carried out using the 1H body coil and
the tissue water as a reference signal. In PB a number of pencil beam excitations,
each one with two different echo times, are measured through the volume of interest
to determine phase differences over the beams. In this process, the various orders
of magnetic field gradients present in the subject are calculated and the amount of
electrical current needed to correct unwanted gradients in the subject is estimated.
Estimated currents are applied to the system shim and gradient coils.
In this experiment, eight shim correction components were determined: three
first order (X, Y, Z) and five second order (Z2, ZX, ZY, XY, X2−Y2). Second
order shimming allows better homogeneity over large voxels compared to first order
shimming including linear X ,Y and Z components only. Besides adjusting the shim
currents, the f0-frequency was determined from the tissue water resonance during
the preparation. The total duration of this automatic procedure was approximately
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Figure 22: Transaxial localizer image showing the volume of interest placed in the
the right lobe of the liver.
40 seconds.
3.4.2 Tuning and matching
The presence of patient changes the coil load and thus the characteristics of the
tuned circuit. In order to optimize the performance of the measurement coil, variable
capacitors were adjusted manually by means of long flexible rods (see Figure 21).
The first variable capacitor was used to adjust the tuning - the frequency at which
the tuned circuit resonates. This frequency equals the resonance frequency of 31P
at 3.0 T, approximately 51.73 MHz. To minimize the amount of reflected power,
the second variable capacitor was used to adjust matching - the impedance of the
loaded coil. The impedance should be 50 Ω for zero reflection.
In manual tuning mode, low power RF was swept through the resonance fre-
quency. During tuning, reflected power was monitored as a function of frequency
and had a shape of ”V” (see Figure 23). The adjustment of reflected power curve
was followed from the screen on the front panel of the MR imager. Curve was cen-
tred at zero frequency offset and the shape was adjusted as sharp as possible in
order to achieve optimum resonance frequency and minimize the reflected power.
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Figure 23: Capacitors were adjusted to compensate the load of the subject.
Impedance was matched (vertical axis) in order to minimize reflected signal and
frequency was tuned to resonance frequency of 31P nuclei at 3.0T.
3.4.3 Signal processing and quantification
All spectra were preprosessed and analysed using a jMRUI v3.0 software [86]. The
first two data points in time domain were removed from each FID in order to suppress
wide hump in the spectra [76]. Truncated FIDs were zero filled to 4096 data points
and then apodized with Gaussian function of 10 Hz for Gaussian lineshape fitting and
with exponential function for Lorentzian line shape fitting. Signal intensities were
assessed in time domain using AMARES algorithm (Advanced Method for Accu-
rate, Robust and Efficient Spectral fitting) with prior knowledge [87]. Two different
prior knowledge schemes were used for quantification: the first approach, widely
used in literature, uses 11 Gaussian peaks and second 15 Lorentzian shaped peaks.
Frequencies and line widths were picked from each spectra to be used as starting
values for fitting algorithms with Gaussian and Lorentzian lineshapes. Prior knowl-
edge was used to fix relative frequencies, line widths and signal shapes according to
values presented in Tables 7 and 8. Amplitudes and relative phases were allowed to
be estimated freely for each metabolite. However, overall first order phase (begin
time) was fixed to 0.67 ms, which compensates the removal of the first two time
points from each FID. Example of Gaussian and Lorentzian signal fitting of in vivo
spectra is shown in Figures 24 and 25, respectively.
The peak areas or intensities and Crame´r-Rao bounds (CRB) for signal fits were
assessed for each metabolite. RMS noise levels were estimated from the last 100
points of the original FID. The noise was estimated as root mean squares (RMS)
R(x) =
√
ΣNk=0x
2
k
N
, (47)
where N is number of points and xk is amplitude at point k. Noise was calculated
from both 100 last points of the original FID and residue signal.
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Table 7: Prior knowledge of 31P metabolite peaks, frequences and line widths for
Gaussian lineshape fitting scheme. Amplitudes and relative phases were estimated.
Peak frequency line width
PE estimate estimate
PC PE–30 Hz 1.0×PE
Pi estimate estimate
GPE estimate estimate
GPC GPE–30 Hz 1.0×GPE
PEP 0.9 ppm-2.7 ppm 1.0×GPE
γ-NTP estimate estimate
α-NTP estimate estimate
NADPH α-NTP–40 Hz 1.0×α-NTP
UDPG α-NTP–110 Hz 1.0×α-NTP
β-NTP estimate estimate
SNRs for each signal were calculated dividing the signal amplitudes by the RMS
noise. Relative amplitudes were calculated dividing each intensity by the sum of all
eleven intensities. Means (µ) and standard deviations (σ) were calculated for each
metabolite and also for selected metabolite ratios. Moreover, coefficient of variations
(cv) were calculated by
cv =
σ
µ
(48)
3.5 1H MRS acquisition and signal processing
In vivo 1H MRS of the liver was performed in order to exclude subjects with excess
amount fat in the liver. T1-weighted localization images were collected in transaxial
plane. A 2× 2× 2 cm3 voxel was placed in the right liver lobe avoiding gall bladder
and vascular structures. Unsuppressed 1H MR spectra were obtained using PRESS
localization technique with TE of 31 ms and 16 acquisitions, collecting 1024 dat-
apoints over a 2000 Hz bandwidth. Acquisition localization images and MRS was
triggered to end exhalation using navigator belt, so that the TR for MRS acquisition
was ≥ 4000 ms.
1H MRS spectra were preprocessed and analysed using a jMRUI v3.0 software.
Spectra were zerofilled to 4096 data points and apodized with Gaussian and ex-
ponential filters of 5 Hz for fat and water quantification, respectively. Intensities
of water and methylene resonances were quantified, and liver fat content was de-
termined as a mass fraction as described in detail in a paper by Kotronen et al.
[88].
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Table 8: Prior knowledge of 31P metabolite peaks, frequences and line widths for
Lorentzian lineshape fitting scheme. Peak positions are denoted with u, d and c
for upfield, downfield and center, respectively. Amplitudes and relative phases were
estimated.
Peak frequency line width shape
PE estimate estimate Lorentzian
PC PE–30 Hz 1.0×PE Lorentzian
Pi estimate estimate Gaussian
GPE estimate estimate Lorentzian
GPC GPE–30 Hz 1.0×GPE Lorentzian
PEP 0.9 ppm-2.7 ppm 1.0×GPE Lorentzian
γ-NTP (u) estimate estimate Lorentzian
γ-NTP (d) estimate estimate Lorentzian
α-NTP (u) estimate estimate Lorentzian
α-NTP (d) estimate estimate Lorentzian
NADPH α-NTP–40 Hz 1.0×α-NTP (u) Lorentzian
UDPG α-NTP–110 Hz 1.0×α-NTP (d) Lorentzian
β-NTP (u) estimate estimate Lorentzian
β-NTP (c) estimate estimate Lorentzian
β-NTP (d) estimate estimate Lorentzian
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Figure 24: Signal fitting of in vivo spectrum with Gaussian lineshapes . A) repre-
sents residue, B) individual components of spectrum 1: PE, 2: PC 3: Pi, 4: GPE,
5: GPC, 6: PEP/PtdC, 7: γ-ATP, 8: α-ATP, 9: NADPH, 10: UDPG, 11: β-ATP,
C) estimated total phosphorus singal and D) preprocessed original signal.
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Figure 25: Signal fitting of in vivo spectrum with Lorentzian lineshapes . A) repre-
sents residue, B) individual components of spectrum 1: PE, 2: PC 3: Pi, 4: GPE,
5: GPC, 6: PEP/PtdC, 7-8: γ-ATP, 9-10: α-ATP, 11: NADPH, 12: UDPG, 13-15:
β-ATP, C) estimated total phosphorus singal and D) preprocessed original signal.
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4 Results
4.1 The effect of line broadening and noise on metabolite
concentrations
For quantification, γ-ATP Lorentzian approach was very accurate when inhomoge-
neous component β was absent or small, but concentrations become overestimated
with increasing Gaussian broadening. Gaussian fitting tends to underestimate signal
concentrations independent of the magnitude of Gaussian damping factor. The de-
pendence of quantified γ-ATP intensities on Gaussian broadening have been demon-
strated with different quantification procedures in Figure 26. The effect is demon-
strated on γ-ATP resonance in Figure 26, but the effect is similar for the other
resonances as well. The dependence of Lorentzian lineshape fitting on Gaussian
broadening can be decreased by normalizing the intensities to total phosphorus sig-
nal.
Figure 26: Concentrations of γ-ATP as a function of Gaussian broadening (β) de-
termined by Gaussian and Lorentzian lineshape fitting from simulated spectra.
Standard deviations of the quantitated intensities increase with relative noise as
is seen in Figure 27, where the dependence of quantitated intensities as a function
of spectral noise level is shown for GPC. Moreover, CVs for metabolite intensities
determined by Lorentzian and Gaussian lineshape fits from 20 Monte Carlo simula-
tions with each noise level are shown in Table 10. The advantage of prior knowledge
in the quantification of noisy spectra is demonstrated in Figure 28.
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Figure 27: Concentration of simulatated glycerophosphocholine (GPC) resonance
(α = 30 and α = 20) determined as a function of relative noise determined by
Lorentzian and Gaussian lineshape fitting.
4.2 In vivo 31P MRS
There were no significant differences between the noise calculated from the last
points of the original FID and from the residue signal.
Signal-to-noise ratios from each study subject are presented in Table 11. Intra-
and inter-individual variations for assessment of concentrations of PE, PC, Pi, GPE,
GPC, PEP/PtdC, γ-NTP, α-NTP, NADPH and β-NTP, determined by Gaussian
and Lorentzian lineshape fits are shown in Table 9.
4.3 In vivo 1H MRS
Liver fat content, reported as mass fractions, was very low in all subjects with mean
value of 1.0 ± 0.8 % (± SD) and range 0.3-2.6 %.
50
Figure 28: Dependence of standard deviation (SD) of the Lorenzian lineshape fit
for glycerophosphocholine as function of relative noise. The slope is less steep (red
line) when prior knowledge is utilized compared to fitting without prior knowledge
(pk).
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Table 9: intra- and inter-individual coefficient of variations (CV)for Gaussian and Lorenzian lineshape fits. Total phosphorus
signal has been used as an internal reference. CVs are reported in percents (%).
PE PC Pi GPE GPC PEP γ-NTP α-NTP NADPH β-NTP
Gaussian
intra-individual (n=3) 27 14 7 49 27 60 10 32 61 33
inter-individual (n=6) 46 31 28 29 39 52 24 38 56 67
Lorentzian
intra-individual (n=3) 26 30 7 12 12 31 2 22 59 12
inter-individual (n=6) 41 43 16 26 29 19 10 33 24 37
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Table 10: Coefficient of variations (CV) for Gaussian and Lorentzian lineshape fits
of simulated spectra with varying noise levels. CVs are reported in percents (%).
Noise level (%) 5 10 15 20 30 50
fitting procedure
Gaussian 0.8 1.0 2.7 3.9 4.5 9.4
Lorentzian 1.2 1.8 3.5 5.0 6.7 11.9
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Table 11: Signal-to-noise ratios in in vivo measurements for each metabolite and subject (s1-s6).
PE PC Pi GPE GPC PEP γ-NTP α-NTP NADPH UDGP β-NTP
s1 6 7 12 15 19 4 10 8 4 2 2
s2 2 4 7 6 6 2 10 14 7 4 8
s3 5 6 9 12 14 4 11 16 8 4 7
s4 6 4 12 12 15 6 14 16 11 5 10
s5 5 4 11 13 11 1 9 11 3 4 3
s6 3 2 11 11 13 3 11 18 11 5 9
mean 4 5 10 11 13 3 11 14 7 4 6
sd % 1.4 1.7 2.0 2.9 4.5 1.6 1.7 3.8 3.4 1.1 3.1
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5 Discussion
Generally, Lorentzian line-fitting scheme performed better in in vivo spectra, pro-
ducing lower CVs for both intra- and inter-individual variation as shown in Table
9.
In Lorentzian scheme, Pi, GPE, GPC, γ-NTP and β-NTP showed good repeata-
bility with intra-individual CVs ranging from 2 - 12 %. Low CVs of Pi can be seen
a bit surprising. Even though, Pi resonance is clearly distinguishable, it 1) overlaps
with PME and PDE resonances (Figure 18) and 2) resonates in a frequency region
that has a wide underlying resonance from motion-restricted phospholipids in cell
membrane and vesicle bilayers [89]. In addition, 3) Pi is sensitive to nutritional sta-
tus, since ATP (and GTP) and Pi exchange in dynamic balance [75]. Pi resonance
may also have contributions from 2,3–diphophoglycerate in blood erythrocytes res-
onating at 3.8 ppm. On the other hand, Pi has a short T1 relaxation time and with
TR of 6000 ms, resonance is not T1 weighted (TR≥5T1) at 3.0 Tesla. NOE factor of
Pi (Table 4) is also relatively low. Therefore, Pi is not sensitive to variation in per-
formance of NOE. In this study, issues mentioned above were addressed by 1) using
prior knowledge to minimize effect of signal overlapping, 2) truncating first times
points from the FID to suppress wide baseline hump and 3) instructing subjects to
fast over night to standardize nutritional status.
NTP resonances showed low intra- and relatively low inter-individual variation.
γ-NTP had lowest CV for both intra- and interindividual variation. Higher CVs for
α- and β- can be explained by higher chemical shift artifacts and limited bandwidths
of used pulses. In addition, α-NTP suffers from overlapping of diphosphodiesters
and β-NTP has a lower SNR due to tripled structure. The effect of chemical shift
artifacts and pulse imperfections are expected to be greater in β-NTP compared to
α-NTP.
Our study population was weighted, since there was only one male in compari-
son to five female subjects. However, according to my knowledge, no inter-gender
differences on appearence of in vivo hepatic 31P MR spectra has been reported.
In vivo measurements were performed on low number of subjects. Therefore,
this study should be considered as a demonstrative pilot study.
Possible error sources are described in detail in following sections.
5.1 Discrepancy between simulated and in vivo spectra
Simulated spectra are ideal in many ways. Situation is much more complex in vivo,
and were not disturbing in simulations. Broad resonance arising from phospholipids
[76] was not modelled in these simulations, since it was suppressed in postprocessing
of in vivo spectra by removing first two points in time domain. Incomplete suppres-
sion may still add uncertainty to the quantification of some signals, PDE, Pi and
PEP/PtdC especially.
Each resonance of the spectra were modelled to be of similar linewidth (α and
β). This is a rough approximation and not true for in vivo spectra. Metabolites in
31P MR spectrum of the liver differ in size and molecular shape. Therefore, there
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are variation in spectral linewidths of the metabolites, because of the variation in
magnitude and form of relaxation mechanisms effecting on different metabolites.
Due to limited sensitivity, hepatic 31P MR spectra are averaged from several
acquisitions; 128 acquisitions in this thesis. Uncorrected phase distortion before
averaging may lead to underestimation of metabolite intensities. Therefore, data
should be accquired as a ”time series”, in which each phase cycle (8 acquisitions for
ISIS sequence) is saved as a single frame allowing manual phase correction prior to
signal averaging. However, poor SNR of a single frame can make phase correction
challenging.
β-ATP concentrations appear to be smaller in in vivo experiment (Figure 18)
compared to simulated resonances taken from the literature. The possible reason
may be as follows: β-ATP resonating far right to the downfield at -16.26 ppm may
suffer from large chemical shift artifact and limited bandwidths of pulses.
In phosphomonoester region of the hepatic 31P MR spectra, PE and PC reso-
nances overlap with several other PME resonances leading to poorer spectral resolu-
tion in this spectral region. Also, 2,3–diphophoglycerate contamination from blood
may affect to Pi and PC as discussed later in detail.
5.2 Effects of imperfect localization
ISIS sequence is prone to process known as ’T1 smearing’, an important source of
background contamination. ’T1 smearing’ arises when a non-perfect 90◦ excitation
pulse is used in combination of with short TR (≤5T1). The magnitude of this
contamination depends on excitation pulse angle, inhomogeneous B1 field, TR/T1
ratio and ISIS experiment order [91]. This causes background contamination via
imperfect cancellation of the signals outside the volume of interest.
In order to avoid T1 smearing, one of the 48 optimal experiment orders out of
the 40 320 possible permutations was used. By using optimal experiment order T1
smearing can occur in only one (out of three) of the selected slices. In addition,
frequency modulated 90◦ adiabatic hyperbolic secant pulse was used in order to
achieve 90◦ excitation. However, non-perfect 90◦ flip angles might still occur due to
practical implementation of the pulse.
In phantom measurements with nominal voxel size of 50×50×50 mm3 and fully
relaxed conditions (TR≥5T1), contamination of approximately 10-20 % has been re-
ported [56]. In clinically feasible conditions (TR ≈ T1), background contamination
has been reported to increase from approximately 20 % to over 50 % [56].
By decreasing the voxel size relative background contamination increases. There-
fore use of larger voxel, even if it extends beyond the edges of the tissue is of interest
is recommended [56].
5.3 Signal contamination from non-hepatic tissues
Liver is an organ consisting of not only hepatic cells, but also other tissue types.
Also, liver is prone to cardiac and respiratory motion. Therefore, it is practically
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impossible to measure pure liver parenchyma (i.e. hepatic cells) by in vivo MRS,
which has limited spatial resolution per se.
Hepatic vasculature structures have been reported to be up to 25 % of the total
liver volume [92]. Thus, it is likely that 2,3–diphophoglycerate (2,3–DPG) resonating
from blood erythrocytes will affect to the hepatic 31P MR spectra. At the pH of
blood, 2,3–DPG peaks resonate at 3.8 and 2.8 ppm. It is likely that signals from
blood 2,3–DPG contribute to the PC and Pi and also total phosphorus signal. Li
et al estimated from expected structural volumes and metabolite concentrations
that, in theory, erythrocyte 2,3–DPG could account for up to 45 % of PC and 18
% of Pi signals, when relaxation effects are neglected. Signal contamination from
blood erythrocytes hamper reproducibility (especially inter-individual) of PE and
Pi and also indirectly all metabolites when total phosphorus signal is used as an
internal reference. Blood supply to the liver is increased by exhalation, bed rest and
digestion of food, while standing position and physical exercise will do the opposite.
Besides, effective blood supply, liver can store approximately 300 mL of blood. As
a consequence of a cardiac dysfunction, liver can double its blood storage [93].
The small resonance at 2.06 ppm, upfield side of GPC is not always clearly dif-
ferentiable. Conventionally, this resonance has been assigned to PEP [77, 78], or
extraction and perchlhoric acid artifacts in in vitro studies [94, 71]. PEP is involved
in both glycolysis and gluconeogenesis. The conversion of PEP to ADP by pury-
vate kinase generates one molecule of ATP. In metabolic studies, MRS experiments
are typically performed after a night or several hours of fasting, when increase of
PEP through gluconeosis could be expected. However, reversed phosphorylation of
puryvate to PEP through phosphoenolpuryvate-carboxykinase is considered to be a
rate-limiting step in gluconeogenesis and thus PEP concentrations are expected to
be relatively small [79].
Several in vitro and in vivo studies have shown a dominant peak of phosphatidyl-
choline (PtdC), a typical phosphodiester and part of bile lecithin, resonating at the
same position with PEP. Since voxel size in single voxel 31P MRS is relatively large,
signal contamination from the intrahepatic bile ducts cannot be avoided, but the
voxel has to be placed carefully to avoid contamination from the gall bladder, where
bile is approximately 5 times more concentrated. Also, triggering of respiratory mo-
tion is crucial to avoid contamination from the gall bladder. If contamination occurs,
it can directly hamper the quantification of neighbouring GPC at the downfield side
and indirectly all metabolites if total phosphorus signal is used as an internal refer-
ence. PtdC protects bile ducts from the harmful bile acids [95]. An in vitro NMR
study of human bile has shown conversion PtdC to GPC in patients with primary
sclerosing cholangitis and thus quantitation of PtdC in the liver and gall bladder
may have diagnostic value in the future [96].
Occasionally a small resonance peak can be seen at 0.0 ppm. Phosphocreatine
PCr is a dominant peak in 31P muscle spectrum and thus it’s used as a zero reference
for ppm scale. It has been suggested that PCr is present in small quantities in human
liver [85], but typically it has been considered as a marker of extra-hepatic muscle
contamination [90].
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5.4 Effect of physiological state and diat on metabolite lev-
els
In a recent study, Hakkarainen et al. [75] found decrease of liver NTP after 60 min
exercise session combined with delayed impact of fat intake from standardized fat
rich meal. Both intervention mimiced normal behaviour underlining the importance
standardizing the physiological state prior to hepatic 31P MRS experiment. Fur-
ther, this observation was linked to fueling of gluconeogenesis by ATP and GTP,
supported by various blood samples drawn during the experiment. Since ATP and
Pi exchange in dynamic balance, variations in physiological state may increase vari-
ations in Pi and its, partly overlapping, resonances of PC and GPE at downfield
and upfield sides, respectively.
Abdelmalek et al. [75] reported reduced ATP content in obese type 2 diabetes
mellitus (T2DM) patients with increased habitual diatery fructose consumption
compared to corresponding patients with minimal fructose intake. This study was
performed on patients with T2DM, but it shows large habitual variation in food
intake may increase variation in metabolite levels.
Increased omega 3 fatty acid intake has been shown to effect hepatic 31P MR
spectra of humans. Dagnelie et al. [94] reported a significant increase in PDE to
ATP ratios after 1 and 3 days of 50 mL supplementary fish oil intake (12 g omega 3
fatty acids) compared to baseline measurement. Their in vitro 31P MR spectra on
rat liver extracts further suggested that GPC and possibly GPE were responsible
for rising PDE levels. Also, PC levels were reduced in rat liver after intake of
supplementary fish oil.
5.5 Effects related to measurement parameters
Since ISIS is a FID–based localization technique, metabolites are free from T2
weighting. However, relatively large variation in T1 relaxation times of different
metabolites have been reported. Not only between different studies (Table 12), but
also between subjects inside the same study [39]. Incorporating a T1 measurement
into a study protocol, would require a 4–5 spectral acquisitions with varying inver-
sion recovery times. This would increase the measurement duration approximately
by an hour, which is not feasible in clinical environment. On the other hand, T1
times of almost 10 seconds have been reported for GPE [39] at B0 of 3.0T and,
thus, increasing the TR in order to eliminate T1-weighting, would also lead infeasi-
ble acquisition times. Therefore, some T1–weighting needs to tolerated in practice.
This is present for PDE and also PME resonance with long spin lattice relaxation
times, whereas Pi and NTP resonances with T1 relaxation times less than 1 second
do not suffer from T1-weighting directly. However, when a total phosphorus signal
is used as an internal reference, incomplete recovery of PDE (and PME) will indi-
rectly affect to quantification of these metabolites with short T1 as well. Utilization
of NOE, makes quantification more complex. Contribution of NOE is unique for
each metabolite as shown in Table 4 and depended from environment of metabolites
and external field strenght B0. Therefore, utilization of NOE hampers reliability of
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aquous solutions as an external concentration reference.
5.6 Field strenght considerations
Generally, MR spectroscopy is one of the biggest winners of the higher field strenghts.
Greater energy difference between spin states leads to improved SNR, which often
crucial for nuclei other than proton, as these usually are low in concentration (com-
pared to conventional MRI) and have limited sensitivity (Table 1). In theory, SNR
increases linearly with magnetic field strength as the square of the field strength.
However, situation is more complex in real life. As Larmor frequency increases lin-
early with the field strength according to equation 2, radio-frequency penetration
decreases and T1 relaxation times increase. While B0 increases, CSA becomes in-
creasingly important relaxation mechanism. Whereas the frequency range increases
according to B0, the line widths increase linearly with B
2
0 , limiting the benefits of in-
creased field strength. Also, as relative effects of dipole-dipole interactions decrease,
utility of NOE in boosting SNR decreases. Recently, Chmelik et al. managed to sep-
arate PDE and PME into their subcomponents in hepatic 31P MR spectra at 7.0T
with great success without utilizing proton-decoupling [97]. They also observed that
T1 relaxation times of both PME and PDE resonances increased significantly at 7.0T
compared to 3.0T. However, this was not true for Pi and ATP resonances. Based
on this observation they concluded that dipolar interactions prevail as a dominant
relaxation mechanism over CSA for PDE and PME. Therefore, proton-decoupling
could further improve spectral resolution and NOE SNR in hepatic 31P MRS at
7.0T.
5.7 In summary
This thesis shows that to carry out succesful 31P MR spectroscopy analysis, several
issues have to be considered:
– Lorenzian lineshape fit is sensitive to inhomogeneaus broadening and overes-
timates signal intensities with Gaussian broadening.
– Gaussian lineshape fit underestimates signal intensities, but is not sensitive
for inhomogeneaous broadening.
– Dependence of Lorenzian lineshape fit on inhogeneous broadening can be de-
creased by using the total phosphorus signal as an internal reference.
– Lineshape fitting is insensitive to noise.
– Lorenzian lineshape scheme performed better on in vivo spectra.
In order to to avoid signal contamination from vascular structures and gall blad-
der, attention has to be paid to careful voxel placement, and use of respiratory
triggering if possible. Using long TR minimizes T1-weighting in signal intensities.
Physiologigal state of the study subjects has to be standardized by instructing to
avoid heavy exercise prior to MR experiment and standardizing meal intake.
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Table 12: Hepatic In Vivo T1-values from literature
Study B0 PE PC PME Pi GPE GPC PEP PDE γ-NTP α-NTP NADPH β-NTP
Schmid et al. [39] 3.0T 1.81 2.24 0.73 6.98 4.26 0.43 0.58 0.55
Buchli et al. [90] 1.5T 1.6 0.8 1.9 0.5 0.9 0.5
Wylezinska et al. [50] 1.5T 2.76 4.37
Wylezinska et al. [50] 3.0T 2.80 4.92
Li et al. [59] 1.5T 2.2 2.3 2.1 0.8 5.6 6.6 2.0 6.1 0.4 0.6 2.6 0.4
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